1397 related articles for article (PubMed ID: 32195260)
21. Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
Zou J; Duan D; Yu C; Pan J; Xia J; Yang Z; Cai S
PeerJ; 2020; 8():e10142. PubMed ID: 33150073
[TBL] [Abstract][Full Text] [Related]
22. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
23. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
24. Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.
Jin H; Huang X; Shao K; Li G; Wang J; Yang H; Hou Y
Oncol Lett; 2019 Aug; 18(2):1023-1034. PubMed ID: 31423162
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive analysis of tumor microenvironment-related genes in colon cancer.
Luo R; Guo W; Wang H
Clin Transl Oncol; 2021 Sep; 23(9):1769-1781. PubMed ID: 33689097
[TBL] [Abstract][Full Text] [Related]
26. Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study.
Liu N; Zhang GD; Bai P; Su L; Tian H; He M
World J Clin Oncol; 2022 Aug; 13(8):675-688. PubMed ID: 36160462
[TBL] [Abstract][Full Text] [Related]
27. Benefits of Targeted Molecular Therapy to Immune Infiltration and Immune-Related Genes Predicting Signature in Breast Cancer.
Chen F; Fang J
Front Oncol; 2022; 12():824166. PubMed ID: 35317079
[TBL] [Abstract][Full Text] [Related]
28. Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment.
Xu Y; Xu Y; Wang C; Xia B; Mu Q; Luan S; Fan J
PeerJ; 2021; 9():e11375. PubMed ID: 33987033
[TBL] [Abstract][Full Text] [Related]
29. Immune-related prognostic genes signatures in the tumor microenvironment of sarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Math Biosci Eng; 2021 Mar; 18(3):2243-2257. PubMed ID: 33892543
[TBL] [Abstract][Full Text] [Related]
30. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of prognostic immune-related genes in the tumor microenvironment of ovarian cancer.
Wang J; Su X; Wang C; Xu M
Ann Transl Med; 2022 Jan; 10(2):91. PubMed ID: 35282097
[TBL] [Abstract][Full Text] [Related]
32. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets.
Zhao P; Zhen H; Zhao H; Huang Y; Cao B
J Transl Med; 2023 Mar; 21(1):176. PubMed ID: 36879254
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC).
Li M; Li H; Zhou C; Li X; Gong J; Chen C; Zhang Y
Medicine (Baltimore); 2021 Oct; 100(39):e27332. PubMed ID: 34596136
[TBL] [Abstract][Full Text] [Related]
34. Analysis of core genes for colorectal cancer prognosis based on immune and stromal scores.
Zhu Y; Zhou Y; Jiang H; Chen Z; Lu B
PeerJ; 2021; 9():e12452. PubMed ID: 34820188
[TBL] [Abstract][Full Text] [Related]
35. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
Wu Z; Wan J; Wang J; Meng X; Qian H
Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.
Wei J; Wang B; Gao X; Sun D
Front Cell Dev Biol; 2021; 9():648279. PubMed ID: 34336819
[TBL] [Abstract][Full Text] [Related]
37. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
Zhang Z; Fang T; Lv Y
Front Genet; 2022; 13():934830. PubMed ID: 36171887
[No Abstract] [Full Text] [Related]
38. A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer.
Zhang J; Zhang M; Tian Q; Yang J
Clin Exp Med; 2023 Nov; 23(7):3867-3881. PubMed ID: 37219794
[TBL] [Abstract][Full Text] [Related]
39. CD40LG as a Prognostic Molecular Marker Regulates Tumor Microenvironment Through Immune Process in Breast Cancer.
Yuan M; Pei J; Li R; Tian L; He X; Li Y
Int J Gen Med; 2021; 14():8833-8846. PubMed ID: 34858051
[TBL] [Abstract][Full Text] [Related]
40. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling.
Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B
Front Immunol; 2022; 13():859581. PubMed ID: 35795662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
